MedTrace Logo

Cancer Genome Analysis

NCT01458704 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2011-10-25

No results posted yet for this study

Summary

Next generation sequencing (including targeted gene seqeuncing, exome and transcriptome sequencing) will be performed from fresh frozen tumor samples to understand the genetic alteration of tumors and to aid in optimal selection of further therapeutic agents.

Conditions

  • Malignant Tumor

Interventions

OTHER

next generation sequencing

next generation sequencing (including targeted gene sequencing, exome sequencing, transcriptome sequenicing)

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Tae-You Kim · Seoul National University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2013-04-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01458704 on ClinicalTrials.gov